NCT05722561
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
At risk: Primary completion moved at least 3 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 11 versions: 11 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 15 words
- Primary completion pushed from Nov 1, 2026 to Feb 10, 2027
- Study completion pushed from Mar 1, 2027 to Apr 30, 2027
- Secondary endpoints: details revised at 2 of 9 entries
- Minor Primary completion date: Feb 1, 2027 to Nov 1, 2026v10
- Minor Primary completion date: Nov 1, 2026 to Feb 1, 2027v9
- Minor Enrollment target: 350 to 302
- Primary completion date: Nov 2026 to Nov 1, 2026
- Study completion date: Mar 2027 to Mar 1, 2027
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Jul 2024 to Aug 8, 2024
- Site details revised at 2 of 2 sites
Show 5 earlier versionsHide 5 earlier versions
- Notable Start date: Mar 2024 to Jul 2024
- Study sites: 1 to 2
- Notable Primary completion date: Jan 30, 2025 to Nov 2026
- Study completion date: May 31, 2026 to Mar 2027
- Start date: Feb 29, 2024 to Mar 2024
- Notable Start date: Sep 30, 2023 to Feb 29, 2024v4
- Notable Start date: May 30, 2023 to Sep 30, 2023v3
- Notable Start date: Mar 2023 to May 30, 2023
- Primary completion date: Nov 2025 to Jan 30, 2025
- Study completion date: Mar 2026 to May 31, 2026
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Percentage of Participants who Achieve 100% Reduction in Cigarettes Per Day (CPD) between Baseline and End of Intervention (Visit 5)
Timeframe: Up to Visit 5 (Day 56)
Secondary (9)
Percentage of Participants who Achieve 100% Reduction in CPD between Baseline and Month 6 Follow-Up
Percentage of Participants who Achieve 100% Reduction in CPD between End of Intervention (Visit 5) and Month 6 Follow-Up
Change from Baseline in Self-Reported CPD at End of Intervention (Visit 5)
Change from Baseline in Self-Reported CPD at Month 6
Change from Baseline in Health-Related Quality of Life (HRQOL) Survey Score at End of Intervention (Visit 5)
Show 4 moreShow less
Change from Baseline in Health-Related Quality of Life (HRQOL) Survey Score at Month 6 Follow-up
Number of Respiratory Symptoms Reported at Baseline
Number of Respiratory Symptoms Reported at End of Treatment (Visit 5)
Number of Respiratory Symptoms Reported at Month 6 Follow-up
Arms and interventions
Electronic CigaretteExperimental
Participants in the Electronic Cigarette (EC) arm will receive telehealth motivational counseling for 5 weeks plus the standardized research e-cigarette (SREC).
Nicotine Replacement TherapyActive comparator
Participants in the Nicotine Replacement Therapy (NRT) arm will receive telehealth motivational counseling plus combination NRT (patch and lozenge).
Behavioral: Telehealth Motivational Counseling
Drugs: Nicotine Replacement Product
Devices: National Institute on Drug Abuse (NIDA) Standardized Research Electronic Cigarette (SREC).
Sites
2 sites in 1 country